|Back to main|
Genomic Health, Inc. Enters Oversold Territory - Tale of the Tape
Genomic Health, Inc. 's ( GHDX ) share price has entered into oversold territory with a stochastic value of 11.3322. The Zacks Consensus Estimate on the company's earnings for year ending December 2012 increased by 2 cents over the past month to 18 cents per share. Genomic Health, Inc. is a Zacks #2 Rank ("Buy") company.
GENOMIC HEALTH (GHDX): Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research